One of the earliest phenomena in the atherogenic process in cholesterol-fed rabbits appears to be the trapping oflow density lipoproteins (LDL) at lesion-prone sites in the aorta. The resulting increase in residence time may facilitate oxidation of the lipoproteins, which, in turn, may be a chemotactic signal for monocytes to enter the intima. Oxidized lipoproteins may also be the major source of the cholesterol that the cells accumulate during their transformation into macrophage-derived foam cells (MFC). Adherent monocytes appear to cluster over small groups of subendothelial foam cells, perhaps in response to the enhanced expression of specific adhesion molecules on the surface of endothelial cells and/or monocytes following activation by oxidized lipoproteins. Lipoproteins oxidized by MFC may also injure endothelial cells causing them to retract or rupture. The resulting exposure of the MFC facilitates the formation of mural thrombi. MFC contain oxidation-specific lipid-protein adducts and specificallyexpress the mRNA for 15-lipoxygenase, an enzyme potentially involved in lipoprotein oxidation. MFC isolated from atherosclerotic lesions and containing up to 600 J.Lg cholesterol/mg protein are still capable of binding and degrading modified lipoproteins and affecting the oxidation of LDL.
INTRODUCTION
Although it is generally accepted that some of the earliest cellular responses to hypercholesterolemia involve the adherence of monocytes to the vascular endothelium followed by subendothelial migration and ultimately foam cell formation (14, 16, 24, 25, 29, 42, 51, 53) , it is still unclear what biochemical and molecular mechanisms are involved in stimulating these events. For example, the initial attraction of monocytes to specific lesion prone sites may be due to the oxidation of LDL trapped within the subendothelial space (35, 38) . It is also possible that lipid accumulation within the intima activates endothelial cells to secrete chemotactic factors and express specific adherence molecules (4, 11, 56) . The mechanism(s) underlying the accumulation and retention of lipid by monocytes/macrophages during their transformation into foam cells is also not well understood. Because in vitro studies of monocytes/ macrophages suggest that foam cells will not form in the presence of native LDL, it may be necessary for lipoproteins to be modified in order to be recognized by the "scavenger receptor" of these cells (19, 22, 54) .
The following is a brief review of studies from our laboratories and elsewhere, focusing on the potential role oflipoprotein trapping and oxidation in the initiation and expansion of the fatty streak. The mechanisms discussed include: monocyte adherence and endothelial penetration, macrophage-derived lipoprotein oxidation and foam cell formation, foam cell-induced endothelial injury and activation, and foam cell proliferation. METHODS All of the in vivo studies discussed in this review utilized rabbit models of hypercholesterolemia and atherosclerosis. These include the Watanabe Heritable Hyperlipemic rabbit (WHHL), an animal model of human familial hypercholesterolemia (42, 58) , New Zealand White (NZW) rabbits fed a semisynthetic diet containing low levels of cholesterol (0.025%-0.2%) for up to 18 months so that their 560 plasma cholesterol levels were matched to that of the WHHL rabbit (42, 44) , and NZW rabbits fed high levels of cholesterol (2% added to standard rabbit chow) for between 1 and 16 weeks (49, 50) . In addition, NZW rabbits that had the endothelium of the aorta and iliac arteries denuded using a Fogarty embolectomy catheter, were used for the isolation ofmacrophage-derived foam cells (43) . These animals were fed the 2% cholesterol-containing diet for a total of 13 weeks (1 prior to the catheterization, 12 following the procedure).
All animals used for morphologic, immunocytochemical, or LDL uptake and trapping studies were perfusion fixed at physiologic pressure with either 2.5% glutaraldehyde in 0.1 Mphosphate buffer (14, 29, 42) , formal-sucrose containing 50 ILM BHT and 10 mM EDTA (32, 45) or modified Kamovsky's fixative (48) (49) (50) . In general, the arterial tissue was embedded in paraffin or Epon or was prepared for scanning electron microscopic analysis using standard procedures.
In the studies of LDL uptake into the rabbit arteries (48) (49) (50) , both a conventionally labeled 131 1_ LDL and a 1251-tyramine-cellobiose conjugated LDL were prepared and administered as described. In the studies of foam cell proliferation, the rabbits were administered 3H-thymidine in 3 bolus im injections as described (44) . All immunocytochemical staining was done using an avidin-biotin-alkaline phosphatase or horseradish peroxidase procedure and a panel of polyclonal and monoclonal antibodies generated against epitopes found in oxidized LDL and cell type specific monoclonal antibodies, as described (32, 33, 45, 59) .
Macrophage-derived foam cellswere isolated from the atherosclerotic lesions resulting from the combination of endothelial denudation and cholesterol feeding, using a modification of the enzyme digestion and gradient centrifugation procedures of Berberian et al (2) . The in vitro studies of the cholesterol content of the isolated foam cells as well as the binding and degradation of modified lipoproteins and lipoprotein oxidation were performed using previously published techniques (1, 15, 18, 37, 47, 55) .
RESULTS

LDL Uptake and Trapping at Lesion-Prone Sites
Studies by Schwenke and Carew (49, 50) ofLDL uptake into aorta from NZW rabbits fed cholesterol for up to 16 days demonstrate that at lesion-prone sites (e.g., the aortic arch and the distal edges of branch sites of the abdominal aorta) there is an increase in the concentration of LDL in comparison to lesion-resistant sites within 8-16 days ofthe start of cholesterol feeding and before lesions form (Fig.  1 ). The LDL concentration within the aortic wall at resistant sites increased almost exactly in proportion to the increasing plasma LDL concentration during short-term cholesterol feeding. In contrast, the LDL concentration in susceptible sites of the same vessel increased more. Interestingly, the divergence in the tissue LDL concentrations in the 2 sites by 8-16 days of feeding could not be attributed to a selective change in the permeability in these susceptible, but prelesion, sites. Permeability coefficients for LDL differed among sites, but at no site did they increase during this same interval ofcholesterol feeding (Fig.  2) . These observations suggest that LDL particles entering the wall at susceptible sites are retained for longer and longer intervals relative to LDL particles entering nearby lesion-resistant sites; the net result being an increase in both the relative concentration and residence time of LDL in the susceptible sites. This may in tum be due to local differences in the composition of the extracellular matrix in lesionsusceptible sites.
Modification oj LDL
The increase in the LDL concentration at lesionprone sites occurs well in advance of any increase in the adherence (random or clustered) ofmonocytes to the endothelium or the appearance of subendothelial foam cells (9) . These data suggest that the LDL trapped at these sites may be the agent responsible for the attraction ofmonocytes. However, native LDL is not chemotactic for monocytes nor is it taken up rapidly enough to form foam cells in vitro. This further suggests that the trapped LDL may undergo some type of modification such as oxidation or aggregation ( Fig. 3) (27, 54, 57) .
Previous in vitro studies of cell mediated LDL oxidation have demonstrated that all of the cell types prevalent in atherosclerotic lesions are capable of oxidizing LDL (10, 30, 31, 34, 55) . Further, the same biochemical modifications that occur during cell-mediated oxidation also occur during oxidation in the presence of certain metal ions (Table I) (21, 55) . The in vitro studies of Quinn et al (38) (39) (40) have demonstrated that the LDL which had been oxidized by endothelial cells is chemotactic for monocytes and that there is chemotactic activity in both the phospholipid and other lipid components of the oxidized LDL. Thus, products of the oxidation of LDL may be the actual chemotactic factors involved in attracting the initial group ofmonocytes to lesionprone sites.
Endothelial Activation
Although products of lipoprotein oxidation may be directly chemotactic for monocytes, another pos-TOXICOLOGIC PATHOLOGY
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Abdominal Aorta sibility is that modified lipoproteins may activate endothelial cells or macrophages to secrete specific chemotactic factors (11, 26) . The recent studies of Berliner et al (3, 4) have demonstrated that LDL which is minimally oxidized so that it is not cytotoxic and is still recognized by the LDL receptor, will in fact, stimulate endothelial cells to secrete a protein that is specifically chemotactic for monocytes. In addition, Berliner et al have also demonstrated that preincubation of cultured endothelial cells with minimally oxidized LDL increases the subsequent adherence of monocytes to the endothelial cells (4) .
Oxidized LDL In Vivo
Despite the fact that most of the cell types found within atherosclerotic lesions are capable of oxidizing LDL in vitro, until recently, there was suggestive, but only indirect evidence that oxidized LDL is present in vivo (8, 27) . Using monoclonal antibodies and immune sera specifically generated against products of the oxidation ofLDL (Table II) , we and others have demonstrated that oxidation specific epitopes exist in atherosclerotic lesions from WHHL rabbits at all stages of development (6, 20, 32, 33, 45) . As shown in Fig. 4 , even in the very early streak most of the cells are immunoreactive with antibodies specific for macrophage-derived foam cells.
In addition to the immunocytochemical data, we have also recently shown that LDL that has been gently extracted from atherosclerotic lesions ofboth WHHL rabbits and humans exhibits some of the biochemical properties of oxidized LDL and contains epitopes reactive with our antibodies generated against oxidized LDL (32, 61) . Further, we have also found that there are autoantibodies present in several species that recognize malondialdehyde and 4-hydroxynonenal conjugated LDL (32, 45) and that antioxidant therapy retards the progression of atherosclerosis in the WHHL rabbit (8, 28 
Foam Cell Formation
Scanning electron microscopic examination ofthe endothelial surface of lesion-prone sites of the aorta ofNZW rabbits that had been fed cholesterol for 2-3 weeks (or 1-3 weeks of age in the WHHL rabbits) reveals the presence of isolated, randomly oriented adherent monocytes (42) . When studied at high magnification, many of these monocytes appear to be spread and penetrating through small holes or junctions of the endothelial cells ( Fig. 5 ). Simultaneously, there is the appearance of surface deformations that, when examined in cross section and stained with cell type specific monoclonal antibodies (42, 59) , demonstrates the presence of intimal macrophages (Fig. 6 ). Many of these cells contain large amounts of lipid and have become foam cells ( Fig. 7) . Thus, there are already macrophage-derived foam cells evident within weeks of inducing hypercholesterolemia.
As mentioned previously, it is still unclear how these cells are capable of accumulating such large amounts oflipid. Again, in vitro studies suggest that the cells utilize a "scavenger receptor" which recognizes modified forms of LDL, including oxidized LDL (19, 22, 54) . Our recent studies of freshly isolated macrophage-derived foam cells have further demonstrated that these cells (studied within 24 hr of isolation, a period in which phenotypic modulation probably has not occurred to a large degree) are capable of specifically binding and degrading acetyl-LDL, oxidized LDL and {j-VLDL (43) . In addition, both cultured macrophages and the freshly isolated macrophage-derived foam cells are capable of oxidizing LDL (34, 43) and, as shown above, macrophage foam cells in vivo contain oxidation specific epitopes potentially derived from oxidized LDL. Thus, once the initial influx of monocytes occurs, the modification of trapped or even newly arrived LDL may be effected both by non cellular, auto-oxidation mechanisms and by the monocyte/ macrophages themselves. Therefore, the presence of larger amounts ofoxidized LDL could, in tum, lead to the rapid transformation of any monocyte/macrophages situated in a position to accumulate the oxidized lipoprotein into foam cells.
The next logical question then is how are macrophages capable of effecting lipoprotein oxidation. Again, in vitro studies have suggested several possible mechanisms. These include the generation of superoxide anions, and/or the involvement of cellular lipoxygenases. However, the addition of recombinant superoxide dismutases or xanthine ox-idase inhibitors to cultured macrophages does not inhibit lipoprotein oxidation and xanthine oxidasegenerated superoxide radicals do not oxidize LDL (36) . On the other hand, lipoxygenase inhibitors do retard lipoprotein oxidation and the addition ofpurifled lipoxygenases can directly modify LDL (36) . bits (52) . These observations have led us to look for the presence of 15-LO in macrophages in atherosclerotic lesions.
Using both in situ hybridization with a 15-LO riboprobe and immunocytochemistry with several 15-LO specific antibodies, we have recently observed that IS-LO is specifically expressed and produced by macrophages in fatty streaks and the lateral margins of more advanced lesions in the WHHL rabbit. Further, those cells expressing and producing IS-LO are also immunoreactive for oxidation specific epitopes (62) . Thus, it may be that lipid peroxides generated by IS-LO interact with lipoproteins, possibly at the cell surface, to effect the oxidation of the lipoproteins and facilitate the uptake of lipid and the formation of foam cells.
Foam Cell Mediated Endothelial Injury and Activation
As the macrophages situated immediately beneath the endothelium become more hypertrophic due to the accumulation of lipid, they appear to cause injury to the overlying endothelial cells. As seen in Fig. 8 , a subendothelial foam cell is visible through an area of endothelial cell rupture or retraction. This phenomenon is apparent wherever 
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IMl..Wll. TOXICOLOGIC PATHOLOGY there are subendothelial foam cells, starting with the very earliest fatty streaks. Further, in many cases, when the foam cells become exposed to the circulation, they constitute a thrombogenic surface and mural thrombi frequently form at these sites (14, 29, 42) .
FOAM CELL FORMATIOÑ
There are several possible ways in which the foam cells could cause endothelial injury. First, the upward pressure exerted by the expanding foam cells could cause the endothelial cells to spread or rupture. If the macrophage-derived foam cells are activated (possibly via the uptake of oxidized LDL) (26) , they could secrete proteolytic enzymes (46) or cytokines (13) that could, in turn, injure and/or activate the endothelium. Further, oxidized LDL is itself cytotoxic (10, 23) and, as noted previously, could activate the endothelial cells to secrete chemotactic factors and support the increased adherence of monocytes. A larger scale activation of the endothelium, induced by the increasing number of subendothelial macrophages, could account for the clustering of adherent monocytes that occurs in lesion-prone sites following the initial influx monocytes and formation of the early fatty streak ( Fig.   9 ).
Incubation of endothelial cells in vitro with oxidized LDL also stimulates the expression and secretion of monocyte colony stimulating factor (M-CSF or CSF-l) (41) . Furthermore, northern blot analysis of mRNA extracted from atherosclerotic lesions of cholesterol-fed rabbits demonstrates that M-CSF is expressed in developing lesions (41) .These observations could account for our recent findings that a significant percentage of the cells taking up thymidine in atherosclerotic lesions of the WHHL and cholesterol-fed rabbits are foam cells (Fig. 10) . Simultaneously, using monoclonal antibodies specific for macrophages and smooth muscle cells and tritiated-thymidine autoradiography, we observed that up to 40% of the labeled cells were immunoreactive macrophages (44) . Thus, activation of endothelial cells with oxidized LDL (or even other macrophages and smooth muscle cells) could play a role in stimulating the secretion of growth regulatory molecules and inducing the cell proliferation that is a hallmark of the atherogenic process. Fig. 11 summarizes our current thinking concerning the role that lipoprotein oxidation and cell activation play in the sequence of events that potentially occurs during the initiation and progression of the fatty streak. We believe that the primary event is not the adherence of monocytes to the endothelium, but the trapping of LDL within the matrix at lesion-prone sites (#1 in Fig. 11 ).This trapping could be due to interactions with matrix components (X-LDL in Fig. 11 ) that may be unique to these lesion-prone sites and present in response to hemodynamic influences on these sites (7, 17) . The trapping of LDL and the resulting increase in residence time could facilitate the spontaneous oxidation ofLDL, providing pro-oxidant conditions exist at these sites (#2 in Fig. 11 ).
DISCUSSION
The oxidation ofLDL could, in turn, account for the initial adherence ofsmall numbers ofmonocytes via focal activation of the endothelium (#3 in Fig.  11 ). Activation appears to stimulate the production ofa monocyte specificchemotactic protein (3, 4, 56) which may be identical to the recently described smooth muscle and fibroblast protein called "monocyte chemotactic protein-I (MCP-l)" (56, 60, 63) . In addition, endothelial activation causes a specific increase in monocyte adherence (4) . This may be due to the stimulation of expression of specific adherence molecules, such as those described by Bevilaqua and colleaguesand termed "endothelial-leukocyte-adherence-molecules" or "ELAMs" (5) . ELAMs are expressed by endothelial cells following activation by cytokines such as tumor necrosis factor or interleukin-I (5, 11, 13) . In addition, Cybulsky and Gimbrone have recently described a monocyte specific ELAM that is expressed by endothelial cells, covering atherosclerotic lesions from both WHHL and cholesterol-fed rabbits, but is not expressed by endothelial cells covering normal arteries (12) .
The entry of even small numbers of monocytes into the intima and their transformation into foam cells via uptake of modified LDL (and potential activation during this process) may be the stimulus for the subsequent sequence of events that lead to the initiation and expansion of the fatty streak (#4 in Fig. 11 ). The transformation of the monocytes into foam cells may be due to the uptake ofoxidized LDL, aggregated LDL, or even oxidized-LDL that has formed immune complexes with the auto-antibodies we have observed in several species. Monocyte/macrophages are probably partially responsible for oxidizing the LDL that enters the artery, possibly via a 15-lipoxygenasemediated process. This is supported by our recent observations that there is colocalization of oxidation specific lipid-protein adducts with macrophages, and m-RNA expression and 15-LO secretion by macrophages in atherosclerotic lesions at all stages of development.
A continuously increasing concentration of oxidized LDL and increased numbers of foam cells in the intima could further activate and/or injure endothelial cells and stimulate the adherence and pen-etration of numerous monocytes and their subsequent transformation into the multiple layers offoam cells that constitute the fatty streak (#5 in Fig. 11 ).
Finally, the activation of endothelial cells, macrophages, and smooth muscle cells by oxidized LDL or cytokines could stimulate the secretion of growth regulatory molecules (such as M-CSF) which may be involved in the induction ofthe cell proliferation that accompanies the expansion of the fatty streak and potentially leads to the conversion of the fatty streak to an advanced atheroma (#6 in Fig. 11 ).
